id sid tid token lemma pos ffhd-151 1 1 safety safety NOUN ffhd-151 1 2 test test NOUN ffhd-151 1 3 of of ADP ffhd-151 1 4 a a DET ffhd-151 1 5 supplement supplement NOUN ffhd-151 1 6 , , PUNCT ffhd-151 1 7 5 5 NUM ffhd-151 1 8 - - PUNCT ffhd-151 1 9 aminolevulinic aminolevulinic ADJ ffhd-151 1 10 acid acid NOUN ffhd-151 1 11 phosphate phosphate NOUN ffhd-151 1 12 with with ADP ffhd-151 1 13 sodium sodium NOUN ffhd-151 1 14 ferrous ferrous ADJ ffhd-151 1 15 citrate citrate NOUN ffhd-151 1 16 , , PUNCT ffhd-151 1 17 in in ADP ffhd-151 1 18 diabetic diabetic ADJ ffhd-151 1 19 patients patient NOUN ffhd-151 1 20 treated treat VERB ffhd-151 1 21 with with ADP ffhd-151 1 22 oral oral ADJ ffhd-151 1 23 hypoglycemic hypoglycemic ADJ ffhd-151 1 24 agents agent NOUN ffhd-151 1 25 | | ADV ffhd-151 1 26 functional functional ADJ ffhd-151 1 27 foods food NOUN ffhd-151 1 28 in in ADP ffhd-151 1 29 health health NOUN ffhd-151 1 30 and and CCONJ ffhd-151 1 31 disease disease PROPN ffhd-151 1 32 online online PROPN ffhd-151 1 33 issn issn PROPN ffhd-151 1 34 : : PUNCT ffhd-151 1 35 2160 2160 NUM ffhd-151 1 36 - - SYM ffhd-151 1 37 3855 3855 NUM ffhd-151 1 38 ; ; PUNCT ffhd-151 1 39 print print NOUN ffhd-151 1 40 issn issn PROPN ffhd-151 1 41 : : PUNCT ffhd-151 1 42 2378 2378 NUM ffhd-151 1 43 - - SYM ffhd-151 1 44 7007 7007 NUM ffhd-151 1 45 skip skip NOUN ffhd-151 1 46 to to ADP ffhd-151 1 47 main main ADJ ffhd-151 1 48 content content NOUN ffhd-151 1 49 skip skip ADJ ffhd-151 1 50 to to ADP ffhd-151 1 51 main main ADJ ffhd-151 1 52 navigation navigation NOUN ffhd-151 1 53 menu menu NOUN ffhd-151 1 54 skip skip VERB ffhd-151 1 55 to to PART ffhd-151 1 56 site site VERB ffhd-151 1 57 footer footer ADJ ffhd-151 1 58 open open ADJ ffhd-151 1 59 menu menu NOUN ffhd-151 1 60 functional functional ADJ ffhd-151 1 61 foods food NOUN ffhd-151 1 62 in in ADP ffhd-151 1 63 health health NOUN ffhd-151 1 64 and and CCONJ ffhd-151 1 65 disease disease PROPN ffhd-151 1 66 online online PROPN ffhd-151 1 67 issn issn PROPN ffhd-151 1 68 : : PUNCT ffhd-151 1 69 2160 2160 NUM ffhd-151 1 70 - - SYM ffhd-151 1 71 3855 3855 NUM ffhd-151 1 72 ; ; PUNCT ffhd-151 1 73 print print NOUN ffhd-151 1 74 issn issn PROPN ffhd-151 1 75 : : PUNCT ffhd-151 1 76 2378 2378 NUM ffhd-151 1 77 - - SYM ffhd-151 1 78 7007 7007 NUM ffhd-151 1 79 home home NOUN ffhd-151 1 80 food food NOUN ffhd-151 1 81 science science NOUN ffhd-151 1 82 publisher publisher NOUN ffhd-151 1 83 functional functional ADJ ffhd-151 1 84 food food NOUN ffhd-151 1 85 center center NOUN ffhd-151 1 86 current current ADJ ffhd-151 1 87 archives archive NOUN ffhd-151 1 88 about about ADP ffhd-151 1 89 about about ADP ffhd-151 1 90 the the DET ffhd-151 1 91 journal journal NOUN ffhd-151 1 92 aims aim VERB ffhd-151 1 93 and and CCONJ ffhd-151 1 94 scope scope NOUN ffhd-151 1 95 contact contact NOUN ffhd-151 1 96 editing edit VERB ffhd-151 1 97 services service NOUN ffhd-151 1 98 editorial editorial ADJ ffhd-151 1 99 team team NOUN ffhd-151 1 100 express express VERB ffhd-151 1 101 peer peer NOUN ffhd-151 1 102 review review NOUN ffhd-151 1 103 graphical graphical ADJ ffhd-151 1 104 abstract abstract ADJ ffhd-151 1 105 journal journal NOUN ffhd-151 1 106 insights insight VERB ffhd-151 1 107 privacy privacy NOUN ffhd-151 1 108 statement statement NOUN ffhd-151 1 109 submissions submission NOUN ffhd-151 1 110 announcements announcement NOUN ffhd-151 1 111 search search NOUN ffhd-151 1 112 search search NOUN ffhd-151 1 113 register register NOUN ffhd-151 1 114 login login NOUN ffhd-151 1 115 home home NOUN ffhd-151 1 116 / / SYM ffhd-151 1 117 archives archive NOUN ffhd-151 1 118 / / SYM ffhd-151 1 119 vol vol NOUN ffhd-151 1 120 . . PROPN ffhd-151 2 1 4 4 NUM ffhd-151 3 1 no no NOUN ffhd-151 3 2 . . NOUN ffhd-151 3 3 9 9 NUM ffhd-151 3 4 ( ( PUNCT ffhd-151 3 5 2014 2014 NUM ffhd-151 3 6 ): ): PUNCT ffhd-151 3 7 september september PROPN ffhd-151 3 8 2014 2014 NUM ffhd-151 3 9 / / SYM ffhd-151 3 10 research research NOUN ffhd-151 3 11 articles article NOUN ffhd-151 3 12 safety safety NOUN ffhd-151 3 13 test test NOUN ffhd-151 3 14 of of ADP ffhd-151 3 15 a a DET ffhd-151 3 16 supplement supplement NOUN ffhd-151 3 17 , , PUNCT ffhd-151 3 18 5 5 NUM ffhd-151 3 19 - - PUNCT ffhd-151 3 20 aminolevulinic aminolevulinic ADJ ffhd-151 3 21 acid acid NOUN ffhd-151 3 22 phosphate phosphate NOUN ffhd-151 3 23 with with ADP ffhd-151 3 24 sodium sodium NOUN ffhd-151 3 25 ferrous ferrous ADJ ffhd-151 3 26 citrate citrate NOUN ffhd-151 3 27 , , PUNCT ffhd-151 3 28 in in ADP ffhd-151 3 29 diabetic diabetic ADJ ffhd-151 3 30 patients patient NOUN ffhd-151 3 31 treated treat VERB ffhd-151 3 32 with with ADP ffhd-151 3 33 oral oral ADJ ffhd-151 3 34 hypoglycemic hypoglycemic ADJ ffhd-151 3 35 agents agent NOUN ffhd-151 3 36 authors author NOUN ffhd-151 3 37 naohide naohide PROPN ffhd-151 3 38 yamashita yamashita PROPN ffhd-151 3 39 department department PROPN ffhd-151 3 40 of of ADP ffhd-151 3 41 advanced advanced ADJ ffhd-151 3 42 medical medical ADJ ffhd-151 3 43 science science NOUN ffhd-151 3 44 , , PUNCT ffhd-151 3 45 institute institute NOUN ffhd-151 3 46 of of ADP ffhd-151 3 47 medical medical ADJ ffhd-151 3 48 science science NOUN ffhd-151 3 49 , , PUNCT ffhd-151 3 50 the the DET ffhd-151 3 51 university university NOUN ffhd-151 3 52 of of ADP ffhd-151 3 53 tokyo tokyo PROPN ffhd-151 3 54 , , PUNCT ffhd-151 3 55 tokyo tokyo PROPN ffhd-151 3 56 , , PUNCT ffhd-151 3 57 japan japan PROPN ffhd-151 3 58 ; ; PUNCT ffhd-151 3 59 atai atai PROPN ffhd-151 3 60 watanabe watanabe PROPN ffhd-151 3 61 department department PROPN ffhd-151 3 62 of of ADP ffhd-151 3 63 advanced advanced ADJ ffhd-151 3 64 medical medical ADJ ffhd-151 3 65 science science NOUN ffhd-151 3 66 , , PUNCT ffhd-151 3 67 institute institute NOUN ffhd-151 3 68 of of ADP ffhd-151 3 69 medical medical ADJ ffhd-151 3 70 science science NOUN ffhd-151 3 71 , , PUNCT ffhd-151 3 72 the the DET ffhd-151 3 73 university university NOUN ffhd-151 3 74 of of ADP ffhd-151 3 75 tokyo tokyo PROPN ffhd-151 3 76 , , PUNCT ffhd-151 3 77 tokyo tokyo PROPN ffhd-151 3 78 , , PUNCT ffhd-151 3 79 japan japan PROPN ffhd-151 3 80 ; ; PUNCT ffhd-151 3 81 hikaru hikaru PROPN ffhd-151 3 82 kondo kondo PROPN ffhd-151 3 83 sbi sbi PROPN ffhd-151 3 84 pharmaceuticals pharmaceuticals PROPN ffhd-151 3 85 co. co. PROPN ffhd-151 3 86 , , PUNCT ffhd-151 3 87 ltd ltd PROPN ffhd-151 3 88 . . PROPN ffhd-151 3 89 , , PUNCT ffhd-151 3 90 tokyo tokyo PROPN ffhd-151 3 91 , , PUNCT ffhd-151 3 92 japan japan PROPN ffhd-151 3 93 satofumi satofumi PROPN ffhd-151 3 94 kawata kawata VERB ffhd-151 3 95 sbi sbi PROPN ffhd-151 3 96 pharmaceuticals pharmaceuticals PROPN ffhd-151 3 97 co. co. PROPN ffhd-151 3 98 , , PUNCT ffhd-151 3 99 ltd ltd PROPN ffhd-151 3 100 . . PROPN ffhd-151 3 101 , , PUNCT ffhd-151 3 102 tokyo tokyo PROPN ffhd-151 3 103 , , PUNCT ffhd-151 3 104 japan japan PROPN ffhd-151 3 105 tohru tohru PROPN ffhd-151 3 106 tanaka tanaka PROPN ffhd-151 3 107 sbi sbi PROPN ffhd-151 3 108 pharmaceuticals pharmaceuticals PROPN ffhd-151 3 109 co. co. PROPN ffhd-151 3 110 , , PUNCT ffhd-151 3 111 ltd ltd PROPN ffhd-151 3 112 . . PROPN ffhd-151 3 113 , , PUNCT ffhd-151 3 114 tokyo tokyo PROPN ffhd-151 3 115 , , PUNCT ffhd-151 3 116 japan japan PROPN ffhd-151 3 117 motowo motowo PROPN ffhd-151 3 118 nakajima nakajima PROPN ffhd-151 3 119 sbi sbi PROPN ffhd-151 3 120 pharmaceuticals pharmaceuticals PROPN ffhd-151 3 121 co. co. PROPN ffhd-151 3 122 , , PUNCT ffhd-151 3 123 ltd ltd PROPN ffhd-151 3 124 . . PROPN ffhd-151 3 125 , , PUNCT ffhd-151 3 126 tokyo tokyo PROPN ffhd-151 3 127 , , PUNCT ffhd-151 3 128 japan japan PROPN ffhd-151 3 129 doi doi PROPN ffhd-151 3 130 : : PUNCT ffhd-151 3 131 https://doi.org/10.31989/ffhd.v4i9.151 https://doi.org/10.31989/ffhd.v4i9.151 PROPN ffhd-151 3 132 abstract abstract ADJ ffhd-151 3 133 objective objective NOUN ffhd-151 3 134 : : PUNCT ffhd-151 3 135 this this DET ffhd-151 3 136 study study NOUN ffhd-151 3 137 aimed aim VERB ffhd-151 3 138 to to PART ffhd-151 3 139 examine examine VERB ffhd-151 3 140 the the DET ffhd-151 3 141 safety safety NOUN ffhd-151 3 142 of of ADP ffhd-151 3 143 5 5 NUM ffhd-151 3 144 - - PUNCT ffhd-151 3 145 aminolevulinic aminolevulinic ADJ ffhd-151 3 146 acid acid NOUN ffhd-151 3 147 phosphate phosphate NOUN ffhd-151 3 148 ( ( PUNCT ffhd-151 3 149 5 5 NUM ffhd-151 3 150 - - PUNCT ffhd-151 3 151 ala ala NOUN ffhd-151 3 152 ) ) PUNCT ffhd-151 3 153 with with ADP ffhd-151 3 154 sodium sodium NOUN ffhd-151 3 155 ferrous ferrous ADJ ffhd-151 3 156 citrate citrate NOUN ffhd-151 3 157 ( ( PUNCT ffhd-151 3 158 sfc sfc NOUN ffhd-151 3 159 ) ) PUNCT ffhd-151 3 160 in in ADP ffhd-151 3 161 diabetic diabetic ADJ ffhd-151 3 162 patients patient NOUN ffhd-151 3 163 treated treat VERB ffhd-151 3 164 with with ADP ffhd-151 3 165 one one NUM ffhd-151 3 166 or or CCONJ ffhd-151 3 167 more more ADV ffhd-151 3 168 oral oral ADJ ffhd-151 3 169 hypoglycemic hypoglycemic ADJ ffhd-151 3 170 agents agent NOUN ffhd-151 3 171 ( ( PUNCT ffhd-151 3 172 ohas ohas PROPN ffhd-151 3 173 ) ) PUNCT ffhd-151 3 174 . . PUNCT ffhd-151 4 1 background background NOUN ffhd-151 4 2 : : PUNCT ffhd-151 4 3 recent recent ADJ ffhd-151 4 4 intervention intervention NOUN ffhd-151 4 5 studies study NOUN ffhd-151 4 6 performed perform VERB ffhd-151 4 7 in in ADP ffhd-151 4 8 the the DET ffhd-151 4 9 usa usa PROPN ffhd-151 4 10 and and CCONJ ffhd-151 4 11 japan japan PROPN ffhd-151 4 12 have have AUX ffhd-151 4 13 shown show VERB ffhd-151 4 14 that that SCONJ ffhd-151 4 15 a a DET ffhd-151 4 16 nutritional nutritional ADJ ffhd-151 4 17 supplement supplement NOUN ffhd-151 4 18 of of ADP ffhd-151 4 19 5 5 NUM ffhd-151 4 20 - - PUNCT ffhd-151 4 21 ala ala NOUN ffhd-151 4 22 with with ADP ffhd-151 4 23 sfc sfc NOUN ffhd-151 4 24 efficiently efficiently ADV ffhd-151 4 25 reduced reduce VERB ffhd-151 4 26 blood blood NOUN ffhd-151 4 27 glucose glucose NOUN ffhd-151 4 28 levels level NOUN ffhd-151 4 29 in in ADP ffhd-151 4 30 pre pre ADJ ffhd-151 4 31 - - ADJ ffhd-151 4 32 diabetic diabetic ADJ ffhd-151 4 33 population population NOUN ffhd-151 4 34 without without ADP ffhd-151 4 35 any any DET ffhd-151 4 36 adverse adverse ADJ ffhd-151 4 37 events event NOUN ffhd-151 4 38 . . PUNCT ffhd-151 5 1 thus thus ADV ffhd-151 5 2 , , PUNCT ffhd-151 5 3 it it PRON ffhd-151 5 4 was be AUX ffhd-151 5 5 anticipated anticipate VERB ffhd-151 5 6 that that SCONJ ffhd-151 5 7 5 5 NUM ffhd-151 5 8 - - PUNCT ffhd-151 5 9 ala ala NOUN ffhd-151 5 10 with with ADP ffhd-151 5 11 sfc sfc NOUN ffhd-151 5 12 may may AUX ffhd-151 5 13 potentially potentially ADV ffhd-151 5 14 be be AUX ffhd-151 5 15 taken take VERB ffhd-151 5 16 as as ADP ffhd-151 5 17 a a DET ffhd-151 5 18 beneficial beneficial ADJ ffhd-151 5 19 supplement supplement NOUN ffhd-151 5 20 by by ADP ffhd-151 5 21 diabetic diabetic ADJ ffhd-151 5 22 patients patient NOUN ffhd-151 5 23 who who PRON ffhd-151 5 24 were be AUX ffhd-151 5 25 being be AUX ffhd-151 5 26 treated treat VERB ffhd-151 5 27 with with ADP ffhd-151 5 28 oha oha NOUN ffhd-151 5 29 therapy therapy NOUN ffhd-151 5 30 . . PUNCT ffhd-151 6 1 nevertheless nevertheless ADV ffhd-151 6 2 , , PUNCT ffhd-151 6 3 it it PRON ffhd-151 6 4 is be AUX ffhd-151 6 5 important important ADJ ffhd-151 6 6 to to PART ffhd-151 6 7 examine examine VERB ffhd-151 6 8 its its PRON ffhd-151 6 9 safety safety NOUN ffhd-151 6 10 and and CCONJ ffhd-151 6 11 efficacy efficacy NOUN ffhd-151 6 12 in in ADP ffhd-151 6 13 diabetic diabetic ADJ ffhd-151 6 14 population population NOUN ffhd-151 6 15 . . PUNCT ffhd-151 7 1 methods method NOUN ffhd-151 7 2 : : PUNCT ffhd-151 7 3 this this DET ffhd-151 7 4 study study NOUN ffhd-151 7 5 was be AUX ffhd-151 7 6 a a DET ffhd-151 7 7 prospective prospective ADJ ffhd-151 7 8 single single ADJ ffhd-151 7 9 - - PUNCT ffhd-151 7 10 blinded blind VERB ffhd-151 7 11 , , PUNCT ffhd-151 7 12 randomized randomize VERB ffhd-151 7 13 , , PUNCT ffhd-151 7 14 placebo placebo NOUN ffhd-151 7 15 - - PUNCT ffhd-151 7 16 controlled control VERB ffhd-151 7 17 and and CCONJ ffhd-151 7 18 parallel parallel ADJ ffhd-151 7 19 - - PUNCT ffhd-151 7 20 group group NOUN ffhd-151 7 21 comparison comparison NOUN ffhd-151 7 22 study study NOUN ffhd-151 7 23 . . PUNCT ffhd-151 8 1 medically medically ADV ffhd-151 8 2 treated treat VERB ffhd-151 8 3 diabetic diabetic ADJ ffhd-151 8 4 patients patient NOUN ffhd-151 8 5 between between ADP ffhd-151 8 6 the the DET ffhd-151 8 7 ages age NOUN ffhd-151 8 8 of of ADP ffhd-151 8 9 30 30 NUM ffhd-151 8 10 and and CCONJ ffhd-151 8 11 75 75 NUM ffhd-151 8 12 were be AUX ffhd-151 8 13 recruited recruit VERB ffhd-151 8 14 from from ADP ffhd-151 8 15 the the DET ffhd-151 8 16 tokyo tokyo PROPN ffhd-151 8 17 metropolitan metropolitan ADJ ffhd-151 8 18 area area NOUN ffhd-151 8 19 of of ADP ffhd-151 8 20 japan japan PROPN ffhd-151 8 21 and and CCONJ ffhd-151 8 22 45 45 NUM ffhd-151 8 23 subjects subject NOUN ffhd-151 8 24 were be AUX ffhd-151 8 25 selected select VERB ffhd-151 8 26 after after ADP ffhd-151 8 27 screening screen VERB ffhd-151 8 28 . . PUNCT ffhd-151 9 1 these these DET ffhd-151 9 2 subjects subject NOUN ffhd-151 9 3 were be AUX ffhd-151 9 4 randomly randomly ADV ffhd-151 9 5 assigned assign VERB ffhd-151 9 6 to to ADP ffhd-151 9 7 three three NUM ffhd-151 9 8 groups group NOUN ffhd-151 9 9 : : PUNCT ffhd-151 9 10 daily daily PROPN ffhd-151 9 11 intake intake NOUN ffhd-151 9 12 of of ADP ffhd-151 9 13 15 15 NUM ffhd-151 9 14 mg mg PROPN ffhd-151 9 15 5 5 NUM ffhd-151 9 16 - - PUNCT ffhd-151 9 17 ala ala NOUN ffhd-151 9 18 , , PUNCT ffhd-151 9 19 50 50 NUM ffhd-151 9 20 mg mg PROPN ffhd-151 9 21 5 5 NUM ffhd-151 9 22 - - PUNCT ffhd-151 9 23 ala ala NOUN ffhd-151 9 24 , , PUNCT ffhd-151 9 25 and and CCONJ ffhd-151 9 26 a a DET ffhd-151 9 27 placebo placebo NOUN ffhd-151 9 28 ( ( PUNCT ffhd-151 9 29 n=15 n=15 NUM ffhd-151 9 30 , , PUNCT ffhd-151 9 31 respectively respectively ADV ffhd-151 9 32 ) ) PUNCT ffhd-151 9 33 . . PUNCT ffhd-151 10 1 the the DET ffhd-151 10 2 supplement supplement NOUN ffhd-151 10 3 or or CCONJ ffhd-151 10 4 placebo placebo NOUN ffhd-151 10 5 was be AUX ffhd-151 10 6 administered administer VERB ffhd-151 10 7 for for ADP ffhd-151 10 8 12 12 NUM ffhd-151 10 9 weeks week NOUN ffhd-151 10 10 followed follow VERB ffhd-151 10 11 by by ADP ffhd-151 10 12 a a DET ffhd-151 10 13 four four NUM ffhd-151 10 14 week week NOUN ffhd-151 10 15 washout washout NOUN ffhd-151 10 16 period period NOUN ffhd-151 10 17 . . PUNCT ffhd-151 11 1 the the DET ffhd-151 11 2 primary primary ADJ ffhd-151 11 3 endpoint endpoint NOUN ffhd-151 11 4 was be AUX ffhd-151 11 5 safety safety NOUN ffhd-151 11 6 and and CCONJ ffhd-151 11 7     SPACE ffhd-151 11 8 occurrence occurrence NOUN ffhd-151 11 9 of of ADP ffhd-151 11 10 hypoglycemic hypoglycemic ADJ ffhd-151 11 11 attack attack NOUN ffhd-151 11 12 , , PUNCT ffhd-151 11 13 while while SCONJ ffhd-151 11 14 the the DET ffhd-151 11 15 secondary secondary ADJ ffhd-151 11 16 endpoint endpoint NOUN ffhd-151 11 17 was be AUX ffhd-151 11 18 changes change NOUN ffhd-151 11 19 of of ADP ffhd-151 11 20 fasting fast VERB ffhd-151 11 21 blood blood NOUN ffhd-151 11 22 glucose glucose NOUN ffhd-151 11 23 ( ( PUNCT ffhd-151 11 24 fbg fbg PROPN ffhd-151 11 25 ) ) PUNCT ffhd-151 11 26 and and CCONJ ffhd-151 11 27 hemoglobin hemoglobin NOUN ffhd-151 11 28 a1c a1c PROPN ffhd-151 11 29 ( ( PUNCT ffhd-151 11 30 hba1c hba1c PROPN ffhd-151 11 31 ) ) PUNCT ffhd-151 11 32 . . PUNCT ffhd-151 12 1 results result NOUN ffhd-151 12 2 : : PUNCT ffhd-151 12 3 adverse adverse ADJ ffhd-151 12 4 events event NOUN ffhd-151 12 5 related relate VERB ffhd-151 12 6 to to ADP ffhd-151 12 7 5 5 NUM ffhd-151 12 8 - - PUNCT ffhd-151 12 9 ala ala NOUN ffhd-151 12 10 with with ADP ffhd-151 12 11 sfc sfc NOUN ffhd-151 12 12 were be AUX ffhd-151 12 13 not not PART ffhd-151 12 14 observed observe VERB ffhd-151 12 15 in in ADP ffhd-151 12 16 all all DET ffhd-151 12 17 the the DET ffhd-151 12 18 groups group NOUN ffhd-151 12 19 . . PUNCT ffhd-151 13 1 abnormalities abnormality NOUN ffhd-151 13 2 in in ADP ffhd-151 13 3 blood blood NOUN ffhd-151 13 4 and and CCONJ ffhd-151 13 5 urine urine NOUN ffhd-151 13 6 tests test NOUN ffhd-151 13 7 were be AUX ffhd-151 13 8 not not PART ffhd-151 13 9 observed observe VERB ffhd-151 13 10 either either ADV ffhd-151 13 11 . . PUNCT ffhd-151 14 1 significant significant ADJ ffhd-151 14 2 decrease decrease NOUN ffhd-151 14 3 in in ADP ffhd-151 14 4 fbg fbg PROPN ffhd-151 14 5 was be AUX ffhd-151 14 6 not not PART ffhd-151 14 7 detected detect VERB ffhd-151 14 8 in in ADP ffhd-151 14 9 all all DET ffhd-151 14 10 the the DET ffhd-151 14 11 groups group NOUN ffhd-151 14 12 . . PUNCT ffhd-151 15 1 however however ADV ffhd-151 15 2 , , PUNCT ffhd-151 15 3 there there PRON ffhd-151 15 4 was be VERB ffhd-151 15 5 a a DET ffhd-151 15 6 small small ADJ ffhd-151 15 7 but but CCONJ ffhd-151 15 8 significant significant ADJ ffhd-151 15 9 decrease decrease NOUN ffhd-151 15 10 in in ADP ffhd-151 15 11 hba1c hba1c PROPN ffhd-151 15 12 at at ADP ffhd-151 15 13 4 4 NUM ffhd-151 15 14 and and CCONJ ffhd-151 15 15 8 8 NUM ffhd-151 15 16 week week NOUN ffhd-151 15 17 in in ADP ffhd-151 15 18 the the DET ffhd-151 15 19 15 15 NUM ffhd-151 15 20 mg mg PROPN ffhd-151 15 21 5 5 NUM ffhd-151 15 22 - - PUNCT ffhd-151 15 23 ala ala PROPN ffhd-151 15 24 group group NOUN ffhd-151 15 25 . . PUNCT ffhd-151 16 1 significant significant ADJ ffhd-151 16 2 decrease decrease NOUN ffhd-151 16 3 in in ADP ffhd-151 16 4 hba1c hba1c PROPN ffhd-151 16 5 was be AUX ffhd-151 16 6 not not PART ffhd-151 16 7 observed observe VERB ffhd-151 16 8 in in ADP ffhd-151 16 9 the the DET ffhd-151 16 10 50 50 NUM ffhd-151 16 11 mg mg NUM ffhd-151 16 12 5 5 NUM ffhd-151 16 13 - - PUNCT ffhd-151 16 14 ala ala NOUN ffhd-151 16 15 group group NOUN ffhd-151 16 16 , , PUNCT ffhd-151 16 17 although although SCONJ ffhd-151 16 18 a a DET ffhd-151 16 19 tendency tendency NOUN ffhd-151 16 20 to to PART ffhd-151 16 21 decrease decrease VERB ffhd-151 16 22 after after ADP ffhd-151 16 23 4 4 NUM ffhd-151 16 24 weeks week NOUN ffhd-151 16 25 was be AUX ffhd-151 16 26 apparent apparent ADJ ffhd-151 16 27 . . PUNCT ffhd-151 17 1 conclusion conclusion NOUN ffhd-151 17 2 : : PUNCT ffhd-151 17 3 5 5 NUM ffhd-151 17 4 - - PUNCT ffhd-151 17 5 ala ala NOUN ffhd-151 17 6 with with ADP ffhd-151 17 7 sfc sfc NOUN ffhd-151 17 8 is be AUX ffhd-151 17 9 a a DET ffhd-151 17 10 safe safe ADJ ffhd-151 17 11 and and CCONJ ffhd-151 17 12 potentially potentially ADV ffhd-151 17 13 beneficial beneficial ADJ ffhd-151 17 14 supplement supplement NOUN ffhd-151 17 15 if if SCONJ ffhd-151 17 16 taken take VERB ffhd-151 17 17 by by ADP ffhd-151 17 18 diabetic diabetic ADJ ffhd-151 17 19 patients patient NOUN ffhd-151 17 20 treated treat VERB ffhd-151 17 21 with with ADP ffhd-151 17 22 ohas ohas PROPN ffhd-151 17 23 . . PUNCT ffhd-151 18 1 trial trial NOUN ffhd-151 18 2 registration registration NOUN ffhd-151 18 3 : : PUNCT ffhd-151 18 4 umin umin NOUN ffhd-151 18 5 000008038 000008038 NUM ffhd-151 18 6 key key ADJ ffhd-151 18 7 words word NOUN ffhd-151 18 8 : : PUNCT ffhd-151 18 9 type type NOUN ffhd-151 18 10 2 2 NUM ffhd-151 18 11 diabetes diabetes NOUN ffhd-151 18 12 , , PUNCT ffhd-151 18 13 5 5 NUM ffhd-151 18 14 - - PUNCT ffhd-151 18 15 aminolevulinic aminolevulinic ADJ ffhd-151 18 16 acid acid NOUN ffhd-151 18 17 ( ( PUNCT ffhd-151 18 18 5 5 NUM ffhd-151 18 19 - - PUNCT ffhd-151 18 20 ala ala NOUN ffhd-151 18 21 ) ) PUNCT ffhd-151 18 22 , , PUNCT ffhd-151 18 23 sodium sodium NOUN ffhd-151 18 24 ferrous ferrous ADJ ffhd-151 18 25 citrate citrate NOUN ffhd-151 18 26 ( ( PUNCT ffhd-151 18 27 sfc sfc NOUN ffhd-151 18 28 ) ) PUNCT ffhd-151 18 29 , , PUNCT ffhd-151 18 30 oral oral ADJ ffhd-151 18 31 hypoglycemic hypoglycemic ADJ ffhd-151 18 32 agent agent NOUN ffhd-151 18 33 ( ( PUNCT ffhd-151 18 34 oha oha PROPN ffhd-151 18 35 ) ) PUNCT ffhd-151 18 36 , , PUNCT ffhd-151 18 37 hemoglobin hemoglobin NOUN ffhd-151 18 38 a1c a1c PROPN ffhd-151 18 39 ( ( PUNCT ffhd-151 18 40 hba1c hba1c PROPN ffhd-151 18 41 ) ) PUNCT ffhd-151 18 42 , , PUNCT ffhd-151 18 43 fasting fast VERB ffhd-151 18 44 blood blood NOUN ffhd-151 18 45 glucose glucose NOUN ffhd-151 18 46 ( ( PUNCT ffhd-151 18 47 fbg fbg PROPN ffhd-151 18 48 ) ) PUNCT ffhd-151 18 49 downloads download VERB ffhd-151 19 1 [ [ X ffhd-151 19 2 abstract abstract X ffhd-151 19 3 ] ] X ffhd-151 20 1 [ [ X ffhd-151 20 2 full full ADJ ffhd-151 20 3 article article NOUN ffhd-151 20 4 ] ] PUNCT ffhd-151 20 5 published publish VERB ffhd-151 20 6 2014 2014 NUM ffhd-151 20 7 - - SYM ffhd-151 20 8 09 09 NUM ffhd-151 20 9 - - PUNCT ffhd-151 20 10 13 13 NUM ffhd-151 20 11 issue issue NOUN ffhd-151 20 12 vol vol NOUN ffhd-151 20 13 . . PROPN ffhd-151 20 14 4 4 NUM ffhd-151 20 15 no no NOUN ffhd-151 20 16 . . NOUN ffhd-151 20 17 9 9 NUM ffhd-151 20 18 ( ( PUNCT ffhd-151 20 19 2014 2014 NUM ffhd-151 20 20 ): ): PUNCT ffhd-151 20 21 september september PROPN ffhd-151 20 22 2014 2014 NUM ffhd-151 20 23 section section NOUN ffhd-151 20 24 research research NOUN ffhd-151 20 25 articles article NOUN ffhd-151 20 26 license license NOUN ffhd-151 20 27 authors author NOUN ffhd-151 20 28 retain retain VERB ffhd-151 20 29 the the DET ffhd-151 20 30 copyright copyright NOUN ffhd-151 20 31 of of ADP ffhd-151 20 32 their their PRON ffhd-151 20 33 articles article NOUN ffhd-151 20 34 and and CCONJ ffhd-151 20 35 grant grant VERB ffhd-151 20 36 the the DET ffhd-151 20 37 functional functional ADJ ffhd-151 20 38 food food NOUN ffhd-151 20 39 center center NOUN ffhd-151 20 40 ( ( PUNCT ffhd-151 20 41 ffc ffc NOUN ffhd-151 20 42 ) ) PUNCT ffhd-151 20 43 and and CCONJ ffhd-151 20 44 its its PRON ffhd-151 20 45 journals journal NOUN ffhd-151 20 46 the the DET ffhd-151 20 47 right right NOUN ffhd-151 20 48 of of ADP ffhd-151 20 49 first first ADJ ffhd-151 20 50 publication publication NOUN ffhd-151 20 51 under under ADP ffhd-151 20 52 the the DET ffhd-151 20 53 terms term NOUN ffhd-151 20 54 of of ADP ffhd-151 20 55 the the DET ffhd-151 20 56 creative creative ADJ ffhd-151 20 57 commons common NOUN ffhd-151 20 58 attribution attribution NOUN ffhd-151 20 59 4.0 4.0 NUM ffhd-151 20 60 international international ADJ ffhd-151 20 61 license license NOUN ffhd-151 20 62 . . PUNCT ffhd-151 21 1 this this DET ffhd-151 21 2 license license NOUN ffhd-151 21 3 permits permit VERB ffhd-151 21 4 unrestricted unrestricted ADJ ffhd-151 21 5 use use NOUN ffhd-151 21 6 , , PUNCT ffhd-151 21 7 distribution distribution NOUN ffhd-151 21 8 , , PUNCT ffhd-151 21 9 and and CCONJ ffhd-151 21 10 reproduction reproduction NOUN ffhd-151 21 11 in in ADP ffhd-151 21 12 any any DET ffhd-151 21 13 medium medium NOUN ffhd-151 21 14 , , PUNCT ffhd-151 21 15 including include VERB ffhd-151 21 16 commercial commercial ADJ ffhd-151 21 17 use use NOUN ffhd-151 21 18 , , PUNCT ffhd-151 21 19 provided provide VERB ffhd-151 21 20 the the DET ffhd-151 21 21 original original ADJ ffhd-151 21 22 author(s author(s NOUN ffhd-151 21 23 ) ) PUNCT ffhd-151 21 24 and and CCONJ ffhd-151 21 25 source source NOUN ffhd-151 21 26 are be AUX ffhd-151 21 27 properly properly ADV ffhd-151 21 28 credited credit VERB ffhd-151 21 29 . . PUNCT ffhd-151 22 1 authors author NOUN ffhd-151 22 2 may may AUX ffhd-151 22 3 post post VERB ffhd-151 22 4 and and CCONJ ffhd-151 22 5 share share VERB ffhd-151 22 6 their their PRON ffhd-151 22 7 published publish VERB ffhd-151 22 8 work work NOUN ffhd-151 22 9 freely freely ADV ffhd-151 22 10 , , PUNCT ffhd-151 22 11 provided provide VERB ffhd-151 22 12 that that SCONJ ffhd-151 22 13 the the DET ffhd-151 22 14 original original ADJ ffhd-151 22 15 publication publication NOUN ffhd-151 22 16 in in ADP ffhd-151 22 17 this this DET ffhd-151 22 18 journal journal NOUN ffhd-151 22 19 is be AUX ffhd-151 22 20 acknowledged acknowledge VERB ffhd-151 22 21 . . PUNCT ffhd-151 23 1 by by ADP ffhd-151 23 2 submitting submit VERB ffhd-151 23 3 to to ADP ffhd-151 23 4 this this DET ffhd-151 23 5 journal journal NOUN ffhd-151 23 6 , , PUNCT ffhd-151 23 7 authors author NOUN ffhd-151 23 8 confirm confirm VERB ffhd-151 23 9 that that SCONJ ffhd-151 23 10 their their PRON ffhd-151 23 11 manuscripts manuscript NOUN ffhd-151 23 12 are be AUX ffhd-151 23 13 original original ADJ ffhd-151 23 14 , , PUNCT ffhd-151 23 15 not not PART ffhd-151 23 16 under under ADP ffhd-151 23 17 consideration consideration NOUN ffhd-151 23 18 elsewhere elsewhere ADV ffhd-151 23 19 , , PUNCT ffhd-151 23 20 and and CCONJ ffhd-151 23 21 that that SCONJ ffhd-151 23 22 they they PRON ffhd-151 23 23 hold hold VERB ffhd-151 23 24 the the DET ffhd-151 23 25 necessary necessary ADJ ffhd-151 23 26 rights right NOUN ffhd-151 23 27 to to PART ffhd-151 23 28 grant grant VERB ffhd-151 23 29 this this DET ffhd-151 23 30 license license NOUN ffhd-151 23 31 . . PUNCT ffhd-151 24 1 the the DET ffhd-151 24 2 functional functional ADJ ffhd-151 24 3 food food NOUN ffhd-151 24 4 center center NOUN ffhd-151 24 5 encourages encourage VERB ffhd-151 24 6 open open ADJ ffhd-151 24 7 scientific scientific ADJ ffhd-151 24 8 exchange exchange NOUN ffhd-151 24 9 and and CCONJ ffhd-151 24 10 allows allow VERB ffhd-151 24 11 derivative derivative ADJ ffhd-151 24 12 and and CCONJ ffhd-151 24 13 extended extended ADJ ffhd-151 24 14 works work NOUN ffhd-151 24 15 , , PUNCT ffhd-151 24 16 provided provide VERB ffhd-151 24 17 attribution attribution NOUN ffhd-151 24 18 to to ADP ffhd-151 24 19 the the DET ffhd-151 24 20 original original ADJ ffhd-151 24 21 publication publication NOUN ffhd-151 24 22 is be AUX ffhd-151 24 23 maintained maintain VERB ffhd-151 24 24 . . PUNCT ffhd-151 25 1 about about ADP ffhd-151 25 2 the the DET ffhd-151 25 3 journal journal NOUN ffhd-151 25 4             SPACE ffhd-151 25 5 editing edit VERB ffhd-151 25 6 services service NOUN ffhd-151 25 7             SPACE ffhd-151 25 8 graphical graphical ADJ ffhd-151 25 9 abstract abstract ADJ ffhd-151 25 10             SPACE ffhd-151 25 11 journal journal NOUN ffhd-151 25 12 insights insight NOUN ffhd-151 25 13                 SPACE ffhd-151 25 14 submissions submission NOUN ffhd-151 25 15                 SPACE ffhd-151 25 16 editorial editorial ADJ ffhd-151 25 17 team team NOUN ffhd-151 25 18                 SPACE ffhd-151 25 19 privacy privacy NOUN ffhd-151 25 20 statement statement NOUN ffhd-151 25 21                 SPACE ffhd-151 25 22 contact contact NOUN ffhd-151 25 23                 SPACE ffhd-151 25 24 current current ADJ ffhd-151 25 25                 SPACE ffhd-151 25 26 archives archive NOUN ffhd-151 25 27     SPACE ffhd-151 25 28 open open ADJ ffhd-151 25 29 journal journal NOUN ffhd-151 25 30 systems system NOUN ffhd-151 25 31 hosting host VERB ffhd-151 25 32 and and CCONJ ffhd-151 25 33 support support NOUN ffhd-151 25 34 by by ADP ffhd-151 25 35 : : PUNCT ffhd-151 25 36 openjournalsystems.com openjournalsystems.com X